Evaluation of Drug Display in Critical Care Setting
This trial is active, not recruiting.
|Sponsor||University of Utah|
|Collaborator||National Institutes of Health (NIH)|
|Start date||July 2003|
|End date||October 2013|
|Trial size||200 participants|
|Trial identifier||NCT00715507, 1 R43 GM066615-01A2, 10599|
To assess the clinical utility of the graphical medication monitor, results of the anesthetics for which the display was present will be compared to the results of the anesthetics in which there was no display.
assess differences between medication administration data and patient information with and without the use of the graphical medication monitor.
time frame: preoperative, intraoperative and postoperative
Male or female participants at least 18 years old.
Inclusion Criteria: - Board certified attending anesthesiologists at the University of Utah Health Sciences Center and supervised anesthesiology residents and have been trained on the graphic display Exclusion Criteria: - Board certified attending anesthesiologists at the University of Utah Health Sciences Center and supervised anesthesiology residents that have not been trained on the graphic display
|Official title||Evaluation of Drug Display in Critical Care Setting|
|Principal investigator||Ken Johnson|
|Description||This study has two objectives: First, before the medication monitor is shown to anesthesiologists in a clinical setting, the PKPD models must be validated to assess the clinical reliability of the model-based predictions for patients undergoing general anesthesia. Second, once the PKPD models have been successfully validated, presenting it to anesthesiologists during administration of anesthesia will assess the impact of the graphical medication monitor. Differences in performance and patient care will be determined by comparing anesthesiologists who are presented with the monitor to those who care for patients without the monitor.|
Call for more information